Nabriva Therapeutics Plc Overview
Nabriva Therapeutics Plc Discounted Cash Flow
DCF Analysis for NBRV.
Get informed when a big investor buys or sells
+ FollowFair Value
$5.13
Current Fair Value
$5.13
↑ 261.3% Upside
Undervalued by 261.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison